Elanco Animal Health Incorporated Common Stock vs Grab Holdings Ltd. — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.89 (market cap $11.26B), while Grab Holdings Ltd. trades at $3.2 (market cap $12.72B). The key difference: Elanco Animal Health Incorporated Common Stock and Grab Holdings Ltd. are close in size by market cap, and Elanco Animal Health Incorporated Common Stock is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and Grab Holdings Ltd. for 94 Days on average.
| ELAN | GRAB | |
|---|---|---|
Market Cap | $11.26B | $12.72B |
Volume | 4,570,386 | 65,352,859 |
Sector | Health | Technology |
52-Week High | $26.84 | $6.17 |
52-Week Low | $19.76 | $2.80 |
Typical Hold Time | 1 Days | 94 Days |
Enterprise Value | $14.65B | $8.46B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Grab Holdings (GRAB) trades at $3.195, up 3.73% today, showing strong momentum after recent volatility. The stock demonstrates improving fundamentals with revenue growing from $2.8B in 2024 to $3.37B in 2025 and achieving profitability with $268M net income. Recent Q2 2026 earnings beat expectations with $0.06 EPS versus $0.05 expected, while technical indicators show bearish signals despite neutral oscillators. The company's $1.49B acquisition of Atome Financial positions it for financial services expansion.
Grab presents a compelling turnaround story with accelerating revenue growth and recent profitability. The strong analyst consensus (91.67% buy ratings) and $30M CEO share purchase signal confidence, though technical weakness and competitive pressures in Southeast Asia's ride-hailing market warrant caution. Key catalysts include continued execution on profitability targets and successful integration of Atome acquisition.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →